z-logo
open-access-imgOpen Access
Effect of Maintenance Azithromycin on Established Bronchiolitis Obliterans Syndrome in Lung Transplant Patients
Author(s) -
Nancy R. Porhownik,
Wael Batobara,
W. Kepron,
Helmut Unruh,
Zoheir Bshouty
Publication year - 2008
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2008/158681
Subject(s) - medicine , azithromycin , bronchiolitis obliterans , lung transplantation , lung , pulmonary function testing , surgery , antibiotics , microbiology and biotechnology , biology
Bronchiolitis obliterans syndrome (BOS), the main cause of late mortality following lung transplantation, is defined as an irreversible decline in forced expiratory volume in 1 s (FEV1). Previous studies using azithromycin for BOS in lung transplant patients have demonstrated a potential reversibility of the decline in FEV1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom